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Abstract
Objective—To explore myelin components and mitochondrial changes within the central
nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or
mitochondrial DNA (mtDNA) mutations.
Design—Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-
time and long-range polymerase chain reaction were used to determine the pathogenicity of
mtDNA deletions.
Setting—Department of Clinical Pathology, Columbia University Medical Center, and
Newcastle Brain Tissue Resource.
Patients—Seventeen patients with mitochondrial disorders and 7 controls were studied from
August 1, 2009, to August 1, 2010.
Main Outcome Measure—Regions of myelin-associated glycoprotein (MAG) loss.
Results—Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with
oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas
inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG
loss region, high levels of mtDNA deletions together with cytochrome- c oxidase–deficient cells
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and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter
and glia than axons) confirmed the pathogenicity of mtDNA deletions.
Conclusion—Primary mitochondrial respiratory chain defects affecting the white matter, and
unrelated to inflammation, are associated with MAG loss and central nervous system
demyelination.
Demyelination resulting from oligodendrocyte dysfunction or a distal “dying-back”
oligodendrogliopathy has been distinguished from direct injury to myelin based on
preferential loss of myelin-associated glycoprotein (MAG).1-6 MAG is expressed in
oligodendrocyte processes at the axoglial junction, the most distal part of the cell.7
Preferential loss of MAG relative to myelin basic protein (MBP) and damage to
oligodendrocyte processes are neuropathologic features described in acute lesions of
multiple sclerosis (MS), white matter stroke (WMS), and progressive multifocal
leukoencephalopathy (PML).1,3- 5,8- 9 Cellular energy failure has been implicated in the
pathogenesis of demyelination under these inflammatory and hypoxic conditions, where
modes of tissue damage are multiple. Whether preferential loss of MAG is a feature of
primary mitochondrial disorders,10 due to either mutations in nuclear genes encoding
mitochondrial proteins or mitochondrial DNA (mtDNA) and where inflammation is
minimal, is not known.
Mitochondria are responsible for the generation of adenosine triphosphate through oxidative
phosphorylation.11 However, they are also known to play a pivotal role in apoptosis and
calcium handling. Uniquely, mitochondria contain their own circular genome (mtDNA),
which encodes for 13 subunits of the mitochondrial respiratory chain complexes, all
excluding complex II.11 The central nervous system (CNS) is frequently affected in primary
mitochondrial disorders, and white matter disease (myelinopathy) is described as the
neuropathologic hallmark of Kearns-Sayre syndrome (KSS).10- 13 Whether there is evidence
of preferential MAG loss in KSS, which is caused by either a clonally expanded, single,
large-scale deletion or a complex rearrangement of mtDNA or indeed other primary
mitochondrial disorders where the gray matter is predominantly affected, is not known.
In this study, we explored the expression of CNS myelin components, including MAG and
MBP, in autopsy tissue from patients with well-characterized primary mitochondrial
disorders, including KSS, myoclonic epilepsy with ragged red fibers, mitochondrial
encephalopathy lactic acidosis and strokelike episodes, mitochondrial neurogastrointestinal
encephalomyopathy, Leber hereditary optic neuropathy, and mitochondrial disease due to
POLG (mitochondrial DNA polymerase gamma) mutations (Table).10,17 We show
preferential loss of MAG in patients with KSS. In patients with mitochondrial disorders
other than KSS, preferential MAG loss was not present, and all myelin components were
equally lost within affected regions. High levels of mtDNA deletions, cytochrome-c oxidase
(COX)–deficient cells, and a loss of mitochondrial respiratory chain complex subunits in a
MAG loss region in KSS confirmed the pathogenicity of mtDNA mutations. Our findings in
KSS indicate an association between mitochondrial respiratory deficiency in white matter
and the development of distal dying-back oligodendrogliopathy.
METHODS
Autopsy Samples
Samples from patients 2 through 5, 10, 11, and 14 were obtained from the Department of
Clinical Pathology, Columbia University Medical Center, and the remaining samples were
from the Newcastle Brain Tissue Resource. All cases of mitochondrial disease were
diagnosed before death, and these patients underwent standard diagnostic tests, including a
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muscle biopsy. Patient 1 with KSS developed a left-sided, divergent strabismus at the age of
3 years. She developed bilateral ptosis and progressive external ophthalmoplegia at 15 years
of age and impaired vision and trifascicular block at 27 years of age. In addition, neurologic
examination revealed impaired cognition and hearing, retinal pigmentation, proximal
myopathy, and marked cerebellar ataxia. Magnetic resonance imaging of the brain revealed
white matter hyperintensities and cerebellar atrophy. A muscle biopsy revealed COX-
deficient, ragged red fibers (5%), and a single, large-scale mtDNA deletion was detected in
routine diagnostic testing. She died at 40 years of age after a respiratory infection. Details of
patients 2 and 3, who had KSS due to 12.2- and 10.3-kb mtDNA deletions, respectively,
were previously reported in a study of respiratory chain subunit expression.14 A number of
additional patients with mitochondrial disease due to mtDNA or nuclear DNA mutations and
age-matched controls without neurologic disease were evaluated (Table). The diseases
included Leber hereditary optic neuropathy, mitochondrial encephalopathy lactic acidosis
and strokelike episodes, myoclonic epilepsy with ragged red fibers, mitochondrial
neurogastrointestinal encephalomyopathy, and POLG mutations. All cases received a
molecular diagnosis after death.
In total, 54 fixed tissue blocks from patients with primary mitochondrial disorders were
studied. Inflammatory components were compared with cases (eTable 1) in which MAG
loss has already been reported (pattern III MS,9 WMS,1 and PML8).
Tissue Preparation And Immunohistochemical Analysis
Formalin-fixed, paraffin-embedded (FFPE) and snap-frozen tissues from the cerebral and
cerebellar hemispheres and the spinal cord were processed as previously described.17
Institutional ethical approval was obtained for all tissues used in this study. To evaluate the
extent and nature of neuropathologic changes, we applied routine histopathologic stains on
FFPE tissue sections, including cresyl fast violet stain for the neuronal population density,
Loyez stain for myelin, and Bielschowsky silver stain for axons. Immunohistochemical
analysis was performed on 5 μm of FFPE tissue from the cerebellum, occipital lobe, spinal
cord, and frontal and parietal lobes using a number of antibodies against myelin, axons,
macrophages, and mitochondrial proteins (eTable 2). Detection of primary antibodies was
performed using a polymer detection system (Menapath kit; Menarini Diagnostics),
visualized with 3,3′-diaminobenzidine. Loss of MAG when remaining myelin proteins were
relatively spared was termed preferential MAG or MAG loss.
Quantification Of Olig2- And Cd68-Positive Cells And Densitometric Analysis Of Myelin
Immunoreactivity
The number of CD68- and Olig2-positive cells stained using the corresponding antibodies
was determined in regions of white matter with an area of approximately 10 000 μm2 using
StereoInvestigator software (MBF Bioscience). Immunoreactivity of myelin components
and 2′,3′-cyclic nucleotide phosphodiesterase (CNPase) was densitometrically assessed
using Axiovision (Carl Zeiss Microimaging GmbH).
Cox And Succinate Dehydrogenase Histochemical Analysis
For histochemical studies, sequential COX (complex IV) and succinate dehydrogenase
(SDH or complex II) analysis was performed, as previously described,18 on 10-μm, snap-
frozen sections. Images were captured with a BX54 microscope (Olympus America, Inc).
For molecular genetic studies, 20-μm frozen sections were mounted on
polyethylenenaphthalate-membrane slides, subjected to sequential COX and SDH
histochemical analysis, and air-dried after ethanol dehydration. A variety of different regions
were excised using a Leica Laser Microdissection System (Leica Microsystems) and lysed
overnight according to previous methods.19
Lax et al. Page 3
Arch Neurol. Author manuscript; available in PMC 2013 June 05.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Neuronal Density
We subjected 20-μm FFPE cerebellar sections from KSS patients and 7 age-matched
controls to cresyl fast violet stain and subsequently analyzed the sections using
StereoInvestigator software (MBF Bioscience). The boundaries of the gray matter were
outlined, and the total number of neurons, defined by possessing a nucleolus and clear cell
body profile, were counted. A neuronal cell density was then derived.
Long-Range Polymerase Chain Reaction
Long-range polymerase chain reaction (PCR) was performed using the Expand Long
Template PCR system and DNA was extracted from homogenates of specific brain sections
prepared using a QIAamp DNA Micro Kit (QIAGEN, Inc) per the manufacturer’s
guidelines. The following cycle conditions were used: 3 minutes at 93°C; 10 cycles of 93°C
for 30 seconds, 58°C for 30 seconds, and 68°C for 12 minutes; 20 cycles of 93°C for 30
seconds, 58°C for 30 seconds, and 68°C for 12 minutes plus 5 seconds per additional cycle;
and a final extension of 11 minutes at 68°C. The PCR products were diluted 1:30, and 1 μL
was used as a template for a second round of amplification using the same conditions as
previously mentioned. Primers were designed to cover the major arc of the mitochondrial
genome, as previously described.20 DNA from a normal blood sample was used as a positive
control.
Gel Extraction And Sequencing
To confirm the presence of mtDNA deletions, amplified products were extracted using a gel
extraction kit (QIAGEN, Inc) and cycle sequenced on an ABI3100 Genetic Analyzer
(Applied Biosystems), as previously described.20 Sequences were compared with the revised
Cambridge reference sequence using SeqScape software (Applied Biosystems).
Real-Time Pcr
A multiplex real-time PCR assay using specific fluorogenic Taqman probes (Applied
Biosystems) was used to determine the relative amplification of mtDNA within the MTND1
and MTND4 genes, as previously described.19 This quantitative assay allows for calculation
of the percentage level of deleted mtDNA and was performed in a control (white and gray
matter), KSS patient 1 (white and gray matter), KSS patient 15 (POLG mutation; white
matter), and KSS patient 17 (POLG mutation; white matter).
Statistical Analysis
Two-way analysis of variance was used to assess differences between more than 2 groups.
The Bonferroni test was used to compare differences between 2 selected groups. Minitab
statistical software, version 15 (Minitab, Inc), was used and P < .05 was considered
significant.
RESULTS
We determined the pattern of MAG, MBP, myelin oligodendrocyte glycoprotein (MOG),
and CNPase loss in a number of primary mitochondrial disorders due to mutations of
mtDNA (deletions or point mutations) or nuclear genes encoding mitochondrial proteins
(Table).10,17 We then performed a detailed analysis of mtDNA and mitochondrial
respiratory chain subunits and activity within a preferential MAG loss region and adjacent
gray matter (dentate nucleus) from KSS patient 1, for whom snap-frozen mirror image tissue
blocks were available.
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Preferential Loss Of Mag In KSS
Preferential MAG loss and CNPase loss, which mirrors MAG loss, were seen in KSS
(Figure 1A-D). The MAG and CNPase loss was particularly apparent at high magnification
in cerebellar white matter in KSS patient 1 when compared with controls (Figure 1A and B).
Within the same region, MBP and MOG staining in serial sections was relatively spared
(Figure 1C and D). In all other affected regions in KSS patients (n = 3), preferential MAG
loss was seen in 5 additional regions (eFigure 1A), with the remaining regions showing
equal loss of MBP, MOG, MAG, and CNPase in serial sections. Evaluation of other primary
mitochondrial cases did not show preferential loss of MAG. In mitochondrial disorders other
than KSS, myelin proteins were either intact in regions without neuroaxonal degeneration or
equally absent in regions often with severe neuroaxonal degeneration (eFigure 1B and C and
(eFigure 2).
The assessment of Olig2-positive nuclei showed a significant reduction in oligodendrocyte
lineage cells in the MAG loss regions of all 3 KSS patients compared with controls (Figure
2A, B, and D;P = .006). In contrast, Olig2 nucleus counts did not significantly differ in
nondemyelinated regions of KSS cerebrum compared with corresponding white matter from
control cases or nondemyelinated cerebellum from other mitochondrial cases. There was
evidence of nuclear translocation of the apoptosis-inducing factor, which is stored in the
intermembrane space of mitochondria,21 in MAG loss regions of KSS patients (Figure 2C).
In contrast, only cytoplasmic apoptosis-inducing factor staining was seen within adjacent
neurons in KSS dentate nucleus, consistent with its physiologic localization within
mitochondria. Neuronal density within the dentate nucleus of KSS patient 1, in whom
preferential MAG loss was seen, was comparable (43.20/mm2) to controls (55.86 ± 7.61/
mm2, n = 8), and standard neuropathologic methods revealed relative sparing of axons and
neurons in the dentate nucleus (Figure 2E-G). Given that inflammation was a prominent
feature of all the patients with distal dying-back oligodendrogliopathy, we determined the
density of CD68-positive cells in primary mitochondrial disorders and compared this with
the pattern III MS, WMS, and PML lesions. As expected, the density of CD68-positive cells
in KSS and other primary mitochondrial disorders was significantly lower than in acute
pattern III MS, WMS, or PML lesions (Figure 2H-J, P = .01) and not significantly different
from controls.
Association Of Mag Loss With Pathogenic Levels Of mtDNA Deletion And Respiratory
Deficiency In Oligodendrocytes And Astrocytes
A single mtDNA deletion was detected, using long-range PCR, in tissue homogenates from
dentate nucleus gray and white matter in KSS patient 1, in whom preferential MAG loss was
evident and snap-frozen tissue available (Figure 3A). Sequencing of deleted mtDNA
extracted from long-range PCR identified the deletion breakpoints at positions 11657 and
15636, giving rise to a deletion of 3978 base pairs (bp) associated with an imperfect 12-bp
repeat (Figure 3C). Real-time PCR revealed a significantly higher heteroplasmy level of
mtDNA deletions (the percentage of mutant to total mtDNA copies) in the dentate nucleus
white matter (77.1%) compared with gray matter (44.3%, P = .02). This finding was in
contrast to the patients who harbored multiple mtDNA deletions (3 POLGpatients) and
lacked evidence of preferential MAG, where the levels were low (Figure 3B). The
pathogenicity of the single mtDNA deletion in the white matter of the dentate nucleus in this
case (KSS patient 1) was supported by a disproportionate decrease in the immunoreactivity
of the mitochondrial respiratory chain complex I 30-kDa subunit and the COX subunit I
(COX-I, Figure 4A-D) compared with the complex II 70-kDa subunit and porin in the white
matter. This pathogenicity was also supported by cells lacking COX activity after COX and
SDH histochemical analysis (those cells deficient in COX activity but with intact SDH
activity stain blue) (Figure 4H and eFigure 3D). Oligodendrocytes (Figure 4F, red) and
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astrocytes (Figure 4G, red) in this case contained mitochondria (green) but were devoid of
COX-I (blue) relative to controls (eFigure 3A and B), whereas most axonal mitochondria
contained COX-I (Figure 4E). In contrast to the dentate nucleus white matter, COX-
deficient cells were not present in the dentate nucleus gray matter in this case (eFigure 3C),
and COX and complex II subunits were intact in neurons (Figure 4J-L). Furthermore, COX-
deficient axons were not detected in the white matter. Neurons in the dentate nucleus of this
case were not completely spared by the mtDNA deletion because several cells with faint
complex I 30-kDa staining were observed in the dentate nucleus gray matter neurons (Figure
4K) compared with controls (Figure 4K).
COMMENT
Oligodendrocyte dysfunction and a distal dying-back oligodendrogliopathy are considered
important in the pathogenesis of a number of CNS disorders,22- 23 including MS.9 For the
first time, we show preferential MAG loss, a sign of distal dying-back oligodendrogliopathy,
in a primary mitochondrial disease, KSS.
Several findings in KSS point toward a pathogenic role for mtDNA deletions in the white
matter, including the following: (1) presence of cells devoid of COX activity in white but
not gray matter, (2) more prominent decrease in mitochondrial respiratory chain complex
subunits in white than gray matter, (3) much greater mtDNA deletion levels in dentate
nucleus white matter than in gray matter, and (4) loss of oligodendrocytes and nuclear
translocation of apoptosis-inducing factor in the MAG loss regions, which is similar to
findings after experimental demyelination.24 Compared with the KSS white matter, the
effect of mtDNA deletions on neurons in dentate nucleus was subtle, and axonal injury was
rarely detected where MAG loss was apparent. It is possible that dysfunction of neurons due
to complex I defects contributed to the MAG loss in KSS. In this regard, reports of
preferential MAG loss after wallerian degeneration in spinal cord injury patients and
experimental spinal cord trauma are worthy of note.25- 26 In such situations, preferential
MAG loss occurred in conjunction with loss of axonal proteins and extensive degradation of
the distal portions of axons by calpains. Activated calpains were suggested to also degrade
myelin closest to the axons (MAG) after spinal cord injury.25 In the white matter of KSS
patients, however, the low rate of chronic axonal degeneration is unlikely to have
extensively and diffusely activated calpains, or an unidentified protease,4 to cause the MAG
loss. Furthermore, absence of preferential MAG loss in primary mitochondrial cases other
than KSS, where neurodegeneration is well recognized, suggests that oligodendrocyte
dysfunction in KSS was not secondary to neuronal and axonal degeneration or dysfunction.
The single mtDNA deletion in KSS removed several functionally important protein-coding
and tRNAgenes. Complex I subunits are directly affected, and the removal of specific tRNA
genes would directly lead to a defect in overall mitochondrial protein synthesis, including
COX-I. For a biochemical defect to manifest, the heteroplasmy level of a mtDNA deletion
needs to exceed a certain threshold, generally 60%, because there are multiple copies of
mtDNA in a single cell.27- 28In KSS patients, the white matter showing MAG loss contained
above-threshold heteroplasmy levels of mtDNA deletion, whereas the gray matter and the
corresponding white matter from control cases and those with other primary mitochondrial
disorders harboring mtDNA deletions and without MAG loss (POLG patients) showed
below-threshold levels. The pathogenic levels of mtDNA deletions in the KSS white matter
had rendered both oligodendrocytes and astrocytes respiratory deficient. On the basis of the
findings of this study, it is not possible to establish whether the energy defect in
oligodendrocytes and/or astrocytes was the driving force of oligodendrocyte dysfunction.
Metabolites and ions are exchanged between astrocytes and oligodendrocytes through gap
junctions, disruption of which causes white matter disease, including loss of
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oligodendrocytes.29Whether distal dying-back oligodendrogliopathy due to energy failure is
a direct consequence of mitochondrial defects within oligodendrocytes or an indirect process
due to lack of metabolic support from compromised astrocytes may be investigated using
relevant animal models.
Although preferential MAG loss was detected in 6 of the 54 blocks of rare autopsy tissue
from primary mitochondrial cases, in principle, this study indicates an association between
respiratory deficiency in the white matter and oligodendrocyte dysfunction. The
opportunities to detect preferential MAG loss in postmortem tissue derived from chronic
neurodegenerative disorders are limited. Preferential MAG loss is thought to be an early
neuropathologic sign of oligodendrocyte dysfunction. Most CNS disorders and animal
models of MS with preferential MAG loss have been reported using postmortem tissue after
acute illness, brain biopsies, or tissue from the acute stage of experimental
demyelination.1,9,30 Muscle rather than brain biopsy is the investigation of choice in patients
with suspected primary mitochondrial disorders, and to our knowledge, brain biopsy tissue
from mitochondrial cases is not available. Because postmortem tissues often represent the
late stages of chronic neurodegeneration, it is entirely possible that we might not see
changes directly related to early disease stages. Nevertheless, MAG loss in KSS is an
important finding and shows that genetically determined mitochondrial respiratory chain
defects may cause distal dying-back oligodendrogliopathy in relatively noninflammatory
environments.
Inflammation, hypoxia, and viral infections have been shown to perturb cellular function in
multiple ways, including inhibition of mitochondrial respiratory chain activity.31 Our
findings suggest that mitochondrial defects reported in MS lesions involving
oligodendrocytes and astrocytes may play an important role in CNS demyelination. As
shown in this study, inflammation is not a prominent feature in primary mitochondrial
disorders, and the relative sparing of axons also argues against a hypoxic injury in KSS
patients. Taken together, these observations provide evidence for the proposal that distal
dying-back oligodendrogliopathy in KSS is a primary event due to the high heteroplasmy
levels of mtDNA deletion.13
In summary, we report preferential loss of MAG in KSS patients, in whom the tissue injury
is due to pathogenic levels of mtDNA deletions, causing mitochondrial respiratory chain
dysfunction rather than inflammation or hypoxia. MAG loss in KSS patients, although a rare
finding in postmortem tissue of primary mitochondrial disorders, suggests an important role
for mitochondria in demyelinating disorders of the CNS, such as MS.
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Figure 1.
Pattern of myelin loss within the dentate nucleus in Kearns-Sayre syndrome (KSS). There
was an apparent loss of myelin-associated glycoprotein (MAG) (A-C) and 2′,3′-cyclic
nucleotide phosphodiesterase (CNPase) (D-F) compared with myelin oligodendrocyte
glycoprotein (MOG) (G-I) and myelin basic protein (MBP) (J-L) immunoreactivity within
the dentate nucleus white matter (KSS patient 1). G-I, The loss of MOG was much less
striking than MAG loss in serial sections. At high magnification (original magnification
×63), the loss of MAG (A-C) and CNPase (D-F) in KSS was notable compared with
corresponding control tissue. In contrast, the difference in MOG (G-I) and MBP (J-L)
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immunoreactivity between KSS and control tissue was subtle, if at all. Scale bar represents
12 μm.
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Figure 2.
Injury to oligodendrocytes, relative sparing of axons, and lack of inflammation within
dentate in Kearns-Sayre syndrome (KSS). A-D, Loss of Olig2-positive nuclei showed a
notable decrease in oligodendrocyte lineage cells within the white matter of the dentate
nucleus in KSS patients (B) compared with controls (A and D). Quantitation of Olig2-
positive cells in KSS dentate nucleus white matter demonstrated the loss of
oligodendrocytes to be significant (P = .008, analysis of variance) compared with controls
and patients with mitochondrial encephalopathy lactic acidosis and strokelike episodes
(MELAS) in which myelin-associated glycoprotein (MAG) loss was not detected in the
dentate (D). In nondemyelinated regions in KSS cerebrum, we did not detect a significant
loss of Olig2-positive cells compared with corresponding white matter. Apoptosis-inducing
factor (AIF) was located in the cytoplasm of neurons (C, arrowheads), whereas neuronal
nuclei did not show AIF immunoreactivity. In contrast, numerous nuclei with intense AIF
staining were detected in the KSS dentate white matter where preferential MAG loss was
evident (C, arrows). E-G, Axons in the dentate nucleus white matter, where MAG loss was
apparent, and control tissue were morphologically intact as judged by Bielschowsky silver
stain. Axons in the MAG loss region rarely showed accumulation of synaptophysin, a
marker of fast axonal transport block (G). In contrast, synaptophysin-positive axons were
detected within affected regions with equal loss of myelin components in primary
mitochondrial disorders, reflecting ongoing axonal degeneration (F, arrowheads). H-J, CD68
immunoreactivity was present at levels comparable to controls (I) in KSS dentate white
matter (H), where preferential loss of MAG was apparent. In contrast, CD68-positive cells
were abundant in pattern III multiple sclerosis (MS) (n = 5), white matter stroke (WMS) (n
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= 4), and progressive multifocal leukoencephalopathy (PML) (n = 3) lesions, reported
disorders with distal “dying-back” oligodendrogliopathy (J). Error bars indicate SEM.
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Figure 3.
The single deletion of mitochondrial DNA (mtDNA) within the white matter of the dentate
nucleus in Kearns-Sayre syndrome (KSS) is pathogenic. A, A single deletion of mtDNA was
detected in laser microdissected regions from KSS dentate nucleus white (lane 1) and gray
(lane 2) matter using long-range polymerase chain reaction (PCR); lane 3 shows full-length
amplified product from control DNA sample (meninges). B, Real-time PCR revealed
significantly greater heteroplasmy levels in dentate white and gray matter (P < .001) than the
corresponding regions in control tissue in 3 separate experiments. However, heteroplasmy
levels in KSS dentate white matter (WM) were higher than the 60% threshold and
significantly greater than in gray matter (GM). In primary mtDNA disorders without myelin-
associated glycoprotein loss and due to POLG mutations (3 patients), the heteroplasmy level
in dentate white matter was less than 60% and significantly less than in KSS. C, Sequencing
of the single, large-scale mtDNA deletion extracted from the long-range PCR gel confirms
the 3978–base pair (bp) deletion. The mtDNA deletion removed several key genes and
occurs at the site of an imperfect 12-bp repeat (highlighted).
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Figure 4.
Mitochondrial respiratory chain complex subunit expression and complex IV (COX) activity
in Kearns-Sayre syndrome (KSS) dentate white (WM) and gray (GM) matter. A-D,
Immunohistochemical detection of mitochondrial proteins within dentate nucleus WM
showed comparable density of porin (A) and complex II (SDH) 70-kDa (B) in KSS (Ai and
Bi) and controls (Aii and Bii). There was a notable reduction in complex I 30-kDa (C) and
complex IV subunit-I or COX-I (D) in KSS (Ci and Di) compared with controls (Cii and
Dii). Densitometric analysis showed a significant (P <.001) decrease in complex I 30-kDa
(by 30.7%) and COX-I (by 31.4%) immunoreactivity in KSS (mean [SD], 100.3 [4.4] and
79.9 [5.0] for complex I 30-kDa and COX-I, respectively) compared with controls (144.7
[6.8] and 116.4 [8.0] for complex I 30-kDa and COX-I, respectively). E, Immunofluorescent
labeling of phosphorylated neurofilament (axons, red), mitochondria (porin, green) and Cox-
I (blue) identified a striking loss of COX-I in the nonaxonal population of mitochondria. In
contrast, COX-I is relatively spared in axonal mitochondria. F and G, Immunofluorescent
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labeling of CNPase (oligodendrocytes, red) or glial fibrillary acidic protein (astrocytes, red),
mitochondria (porin, green), and COX-I (blue) confirmed the lack of COX-I–positive
elements within oligodendrocytes (F) and astrocytes (G). Supplementary eFigure 3 shows
COX-I and porin labeling within astrocytes and oligodendrocytes in control tissue. H, COX
and succinate dehydrogenase immunohistochemical analysis identified numerous
respiratory-deficient cells in the KSS dentate nucleus WM (H), however, such cells were
absent in KSS GM and WM from control cases (Supplementary eFigure 3, C-D). I-L, Porin
(I), SDH 70-kDa (J), and COX-I (L) immunoreactivity were not diminished within KSS
dentate nucleus neurons (Ii, Ji, and Li) compared with controls (Iii, Jii, and Lii). However,
complex I 30-kDa was apparently decreased within KSS patient 1 dentate nucleus neurons
(Ki) compared with controls (Kii). Scale bar represents 100 μm.
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Table
Details of Study Patients With Primary Mitochondrial Disorders and Controls
Patient No./
Sex/Age,y PMI, h Genetic Defect Clinical Presentation
No. of
Blocks
Myelin
Loss
Pattern
of MAG Loss
1/F/40 58 Single deletion KSS 5a Yes +
2/F/2214 3 Single deletion KSS 3 Yes +
3/M/1814 4 Single deletion KSS 4a Yes +
4/M/57 4 m.8344A>G MERRF 3a Yes E
5/M/3612 2 m.8344A>G MERRF 4a Yes E
6/F/42 59 m.8344A>G MERRF 2 Yes E
7/F/60 10 m.3243A>G MELAS 2 Yes E
8/F/57 36 m.3243A>G MELAS 2 Yes E
9/M/45 24 m.3243A>G MELAS 2 Yes E
10/F/42 24 m.3243A>G MELAS 2 Yes E
11/F/34 38 m.13094T>C MELAS 5 Yes E
12/M/55 10 m.14709T>C Ataxia 4 Yes E
13/F/3915 46 m.3460G>A LHON plus 3a Yes E
14/NR/3216 17 1504C >T/A3371C MNGIE 4a Yes E
15/M/50 24 POLG mutation; p.A467T, p.X1240Q Ataxia, neuropathy 4a Yes E
16/F/24 83 POLG mutation; P.A467T, p. W748S Ataxia 3a Yes E
17/M/59 67 POLG mutation; p.G848S, P.W748S Ataxia, dementia 2 Yes E
18/M/64 64 Control NA 5a No No
19/M/55 24 Control NA 3a No No
20/M/86 43 Control NA 3a No No
21/M/27 24-48 Control NA 3 No No
22/F/50 82 Control NA 2 No No
23/M/54 <24 Control NA 2 No No
24/M/47 15 Control NA 2 No No
Abbreviation: E, equal loss of all myelin components; KSS, Kearns-Sayre syndrome; LHON, Leber hereditary optic neuropahty; MAG, myelin-
associated glycoprotein; MELAS, mitochondrial encephalopathy lactic acidosis and strokelike episodes; MERRF, myoclonic epilepshy with ragged
red fibers; MNGIE, mitochondrial neurogastrointerstinal encephalomyopathy; NA, not available; PMI, postmortem interval; + loss of MAG and 2′,
3′-cyclic nucleotide phosphodiesterase, with relative sparing of myelin basic protein and muelin oligodendrocyte glycoprotein immunoreactivity
(preferential MAG loss).
aCases where spinal cord sections were investigated.
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